SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Great-West Lifeco Inc. (GWO.TO) trades at a trailing P/E of 16.3, forward P/E of 12.6. Trailing earnings yield is 6.15%, forward earnings yield 7.91%. PEG 13.55.
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (16.3); earnings yield beats bond yields (6.15%).
- Forward P/E 12.6 (down from trailing 16.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 13.55 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 6.15% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 7.91% as earnings recover.
Overall SharesGrow Score: 69/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GWO.TO
Valuation Multiples
P/E (TTM)16.3
Forward P/E12.6
PEG Ratio13.55
Forward PEG0.44
P/B Ratio0.00
P/S Ratio1.65
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.26
Forward EPS (Est.)$5.48
Book Value / Share$0.00
Revenue / Share$42.10
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.15%
Forward Earnings Yield7.91%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.66 |
$46.38B |
$2.76B |
6% |
| 2017 |
$2.17 |
$47.12B |
$2.28B |
4.8% |
| 2018 |
$3.13 |
$44.03B |
$3.09B |
7% |
| 2019 |
$2.49 |
$44.75B |
$2.49B |
5.6% |
| 2020 |
$3.17 |
$60.6B |
$3.08B |
5.1% |
| 2021 |
$3.36 |
$64.45B |
$3.26B |
5.1% |
| 2022 |
$3.86 |
$-2.69B |
$3.73B |
- |
| 2023 |
$2.93 |
$36.73B |
$2.87B |
7.8% |
| 2024 |
$4.21 |
$34.72B |
$4.07B |
11.7% |
| 2025 |
$4.26 |
$39.1B |
$4.12B |
10.5% |
